AXA SA (WBO:CS)
€ 42.81 +0.18 (+0.42%) Market Cap: 87.06 Bil Enterprise Value: 127.69 Bil PE Ratio: 9.43 PB Ratio: 1.86 GF Score: 61/100

Half Year 2025 AXA SA Earnings Call Transcript

Aug 01, 2025 / 09:00AM GMT
Release Date Price: €39.44 (-7.81%)

Key Points

Positve
  • AXA SA (AXAHF) reported strong organic growth with a 7% increase in top-line revenue and an 8% rise in underlying earnings per share.
  • The company maintains a robust capital position with a Solvency II ratio of 220%, reflecting financial stability.
  • AXA SA (AXAHF) achieved margin improvements in P&C and Health, contributing to higher earnings growth.
  • The acquisition of Prima in Italy is expected to enhance AXA's direct franchise and bring scale in a strategic market.
  • Investments in technology and AI are expected to drive future growth and operational efficiency across the group.
Negative
  • Geopolitical tensions and macroeconomic uncertainties pose challenges to the business environment.
  • The company faces negative FX impacts, particularly from a weaker US dollar, affecting net income.
  • The UK market shows signs of softening, with pricing dynamics weaker compared to Continental Europe.
  • AXA SA (AXAHF) has seen a deterioration in the short-term protection book in France due to increased sick leaves.
  • The impact of grandfathered debt loss on solvency is a concern, though partially mitigated by recent sub-debt issuance.
Operator

Good morning, and welcome to AXA's first half 2025 results call. Presenting today are Group CEO, Thomas Buberl; Group Deputy CEO, Frédéric de Courtois; and Group CFO, Alban de Mailly. Also in the room are Guillaume Borie, CEO of AXA France; Patrick Cohen, CEO of AXA Europe; and Scott Gunter, CEO of AXE XL. With that, I turn it over to you, Thomas.

Thomas Buberl Buberl
AXA SA - Chief Executive Officer

Thank you, Arnaud. Good morning to all of you, and thank you very much for joining our first half 2025 earnings call. As you can see from the results that we have published this morning, our business is in excellent shape. We have developed a strong organic growth of plus 7% top line and underlying earnings per share is up 8% at the top of our target range during this plan.

We are generating a very attractive return on equity while maintaining a strong capital position with a Solvency II ratio of 220%. Our results reflect the strength of our model, which is simple, balanced and now with the completion of the sale of AXA IM, completely focused on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot